Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Net Cash Flow: 2020-2025

Historic Net Cash Flow for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $102.3 million.

  • Cellebrite DI's Net Cash Flow rose 258.88% to $102.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.1 million, marking a year-over-year increase of 7762.50%. This contributed to the annual value of $3.3 million for FY2024, which is 96.69% down from last year.
  • Cellebrite DI's Net Cash Flow amounted to $102.3 million in Q3 2025, which was up 17.64% from $87.0 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Net Cash Flow peaked at $102.3 million during Q3 2025, and registered a low of -$102.0 million during Q1 2025.
  • Over the past 3 years, Cellebrite DI's median Net Cash Flow value was $27.1 million (recorded in 2023), while the average stood at $17.4 million.
  • Per our database at Business Quant, Cellebrite DI's Net Cash Flow tumbled by 696.71% in 2024 and then skyrocketed by 663.86% in 2025.
  • Quarterly analysis of 5 years shows Cellebrite DI's Net Cash Flow stood at $36.2 million in 2021, then soared by 107.84% to $75.2 million in 2022, then tumbled by 31.46% to $51.5 million in 2023, then increased by 10.15% to $56.7 million in 2024, then skyrocketed by 258.88% to $102.3 million in 2025.
  • Its Net Cash Flow was $102.3 million in Q3 2025, compared to $87.0 million in Q2 2025 and -$102.0 million in Q1 2025.